A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab

Name: A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab
Published: 1999
License: Public Domain

National Cancer Institute (NCI) · 1999

ClinicalTrials.gov · Datasets · License: Public Domain · 1999

Open Source ↗

breastcancer breastneoplasms coloncancer gastriccancer lungcancer lungneoplasms pancreaticcancer

breast neoplasms, colonic neoplasms, lung neoplasms, pancreatic neoplasms, stomach neoplasms, breast cancer, colon cancer, gastric cancer, lung cancer, pancreatic cancer, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab

Related documents